GuidelinesOther guideline
Antipruritics, including Antihistamines, Anaesthetics, etc.
Dithranol Clobetasol 0.05% Isotretinoin Acitretin Imiquimod topical 5% ATC Code D05AC01 Medicine Dithranol Indication Psoriasis NEMLC Recommendation Not Approved Review Indicators - Availability of registered product - Evidence of efficacy Date Ratified 23 June 2022 ATC Code D07AD Medicine Very potent topical corticosteroid – Group IV: e.g. Clobetasol 0.05% Examples: Crea
| ATC Code | D05AC01 |
| Medicine | Dithranol |
| Indication | Psoriasis |
| NEMLC Recommendation | Not Approved |
| Review Indicators | - Availability of registered product
- Evidence of efficacy |
| Date Ratified | 23 June 2022 |
| ATC Code | D07AD |
| Medicine | Very potent topical corticosteroid – Group IV: e.g. Clobetasol 0.05% Examples: Cream/ointment: Clobetasol propionate 0.05% |
| NEMLC Recommendation | Approved Lowest price high potency corticosteroid to be used |
| Review Indicators | n/a |
| Date Ratified | 20 September 2007 |
| ATC Code | D10BA01 |
| Medicine | Isotretinoin |
| Indication | Moderate to severe recalcitrant nodular acne |
| NEMLC Recommendation | Approved |
| Review Indicators | n/a |
| Date Ratified | 24 June 2021 (Previously reviewed 09 February 2012) |
| ATC Code | D05BB02 |
| Medicine | Acitretin |
| Indication | Severe localized or generalized pustular psoriasis, or severe psoriasis not responding to conventional therapy under the care of a dermatologist |
| NEMLC Recommendation | Approved |
| Review Indicators | n/a |
| Date Ratified | 23 June 2022 |
| ATC Code | D06BB10 |
| Medicine | Imiquimod topical 5% |
| Indication | Anogenital warts |
| NEMLC Recommendation | Not Approved |
| Review Indicators | New evidence |
| Date Ratified | 24 June 2021 |